Technology · Biotechnology R&D expenditure
In 2026, the Democratic Republic of the Congo's expenditure on biotechnology research and development was 1 $. This places the country 153rd out of 197 nations. The lack of investment in biotechnology reflects the overall weakness of the research base: the country's universities and laboratories are chronically underfunded, with priority given to cobalt and copper mining. Congolese scientists working in tropical medicine must rely on grants from international organizations.
Data for 2026 · unit: $
Position
#153 / 197
DR Congo world ranking
Country position on the scale from last to first place for this indicator.
CD
#153
#197#1
Trend
Change over time
Change in indicator over the available period.
0
1990
1
2000
1
2010
3
2020
1
2025
1
2026
Values — $
Comparison
Top countries by Biotechnology R&D expenditure
Where DR Congo stands in the world ranking.
1
CNChina
30 B
1
USUSA
30 B
3
JPJapan
25 B
4
MXMexico
1 B
4
BRBrazil
1 B
6
CACanada
800 M
6
DEGermany
800 M
8
ESSpain
650 M
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Biotechnology R&D expenditure in DR Congo — how much?
Based on 2026 data — 1 $. This is rank #153 out of 197 countries.
What is DR Congo's rank by Biotechnology R&D expenditure?
DR Congo ranks #153 out of 197 countries in the world ranking by «Biotechnology R&D expenditure».
How has Biotechnology R&D expenditure changed in DR Congo?
Over the available period the indicator changed from 0 to 1 $.